4.59MMarket Cap-233P/E (TTM)
0.2831High0.2600Low82.92KVolume0.2830Open0.2620Pre Close22.34KTurnover0.49%Turnover RatioLossP/E (Static)17.28MShares0.700052wk High0.15P/B4.50MFloat Cap0.197252wk Low--Dividend TTM16.95MShs Float2083593.7500Historical High--Div YieldTTM8.82%Amplitude0.1050Historical Low0.2690Avg Price1Lot Size
Theriva Biologics Stock Forum
NEWS
Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
Theriva Biologics (NYSE American: TOVX) announced that the U.S. FDA granted Fast Track Designation (FTD) to its clinical candidate VCN-01 for treating metastatic pancreatic cancer. This designation aims to expedite the drug's development and review process. VCN-01, combined with gemcitabine and nab-paclitaxel, is undergoing a P...
No comment yet